Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoko Ito

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2023
Accumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cellsShoko Ito, Keisuke Kuromiya, Miho Sekai, et al.
Leukemia Research|January 22, 2016
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysisDaisuke Minakata, Shin-ichiro Fujiwara, Shoko Ito, et al.
Annals of Hematology|February 2, 2017
Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemiaShoko Ito, Shin-Ichiro Fujiwara, Kiyomi Mashima, et al.
Annals of Hematology|December 20, 2019
Evaluation of thrombotic events in patients with immune thrombocytopeniaShoko Ito, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematological Oncology|December 8, 2015
The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemiaHirofumi Nakano, Shin-Ichiro Fujiwara, Shoko Ito, et al.
Leukemia & Lymphoma|February 27, 2016
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemiaChihiro Yamamoto, Shoko Ito, Kiyomi Mashima, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangementKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2017
Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOPKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Annals of Hematology|July 2, 2016
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalanMiyuki Sugimoto, Shoko Ito, Kiyomi Mashima, et al.
Bone Marrow Transplantation|November 3, 2020
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host diseaseKaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2023
Accumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cellsShoko Ito, Keisuke Kuromiya, Miho Sekai, et al.
Leukemia Research|January 22, 2016
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysisDaisuke Minakata, Shin-ichiro Fujiwara, Shoko Ito, et al.
Annals of Hematology|February 2, 2017
Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemiaShoko Ito, Shin-Ichiro Fujiwara, Kiyomi Mashima, et al.
Annals of Hematology|December 20, 2019
Evaluation of thrombotic events in patients with immune thrombocytopeniaShoko Ito, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematological Oncology|December 8, 2015
The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemiaHirofumi Nakano, Shin-Ichiro Fujiwara, Shoko Ito, et al.
Leukemia & Lymphoma|February 27, 2016
Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemiaChihiro Yamamoto, Shoko Ito, Kiyomi Mashima, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangementKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2017
Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOPKento Umino, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Annals of Hematology|July 2, 2016
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalanMiyuki Sugimoto, Shoko Ito, Kiyomi Mashima, et al.
Bone Marrow Transplantation|November 3, 2020
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host diseaseKaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Pageof 9